Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q2 2023 Earnings Conference Call July 27, 2023 8:30 AM ET

Company Participants

Chris Ward - Senior Director, Investor Relations

Jan De Witte - President and Chief Executive Officer

Lea Knight - Executive Vice President & Chief Financial Officer

Conference Call Participants

Steven Lichtman - Oppenheimer

Rohan Patel - JP Morgan

Young Li - Jefferies

David Turkaly - JMP Securities

Vik Chopra - Wells Fargo

Samuel Brodovsky - Truist Securities

Ryan Zimmerman - BTIG

Drew Ranieri - Morgan Stanley

Operator

Good day, and thank you for standing by. Welcome to the Integra LifeSciences Second Quarter 2023 Financial Results.

And now I would like to hand the call over to Chris Ward, Senior Director, Investor Relations. Please go ahead.

Chris Ward

Thank you, Lisa. Good morning, and thank you for joining the Integra LifeSciences second quarter 2023 earnings conference call. Joining me on the call this morning are Jan De Witte, President and Chief Executive Officer; Lea Knight, Chief Financial Officer and Mathieu Aussermeier, Vice President of Corporate FP&A, Investor Relations and Treasurer.

Earlier evening, we issued a press release announcing our second quarter 2023 financial results. The release and corresponding earnings presentation, which we will reference during the call, are available at integralife.com under Investors, Events and Presentations and a file named Second Quarter 2023 Earnings Call Presentation.

Before we begin, I would like to remind you that many of the statements made during this call may be considered forward-looking statements. Factors that could cause actual results to differ materially are disclosed in the company’s Exchange Act reports filed with the SEC and in the release.

Also in our prepared remarks, we will reference both reported and organic revenue growth. Organic revenue growth excludes the effects of foreign currency, acquisitions, divestitures as well as discontinued products. Unless otherwise stated, all this aggregated and franchise-level revenue growth rates are based on organic performance.

Lastly, our comments today will include certain non-GAAP financial measures. Reconciliations of any non-GAAP financial measures can be found in today’s press release, which is an exhibit to Integra’s current report on Form 8-K filed yesterday with the SEC.

And with that, I will now turn the call over to Jan.

Jan De Witte

Thank you, Chris, and good morning, everyone. Let me announce the recall of products from our Boston facility in late May, we committed to sharing the timeline for resuming production in Boston during this earnings call. I appreciate that this is top of mind for our investors and analysts as it is for me and our leadership team. So we’d like to address this first before going into the broader business update.